Magnetic nanometer electrochemical aptamer and sensor for detecting HSP70

By modifying the HSP70 affinity nucleic acid sequence screened in electrochemical sensors on magnetic nanoparticles, the problem of difficulty in targeting substances in electrochemical analysis is solved, and high sensitivity to HSP70 is achieved Detection and rapid analysis enhance the potential of tumor diagnosis and treatment.

CN119082115APending Publication Date: 2024-12-06成都医学院第一附属医院 +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411306620.8
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-09-19
Publication Date
2024-12-06

AI Technical Summary

Technical Problem

Although nucleic acid aptamers in the prior art have a high affinity for target substances, they cannot carry out directed transfer of target substances, which limits their application in electrochemical analysis.

Method used

A magnetic nanoelectrochemical aptamer sensor for detecting HSP70 was designed. The nucleic acid sequence with HSP70 affinity was screened through SELEX technology and modified it on gold-encapsulated magnetic Fe3O4 nanoparticles to realize the aptamer using an external magnetic field. Directed movement and specific binding, thereby achieving high selective screening and diagnosis of HSP70.

Benefits of technology

High sensitivity detection of HSP70 is achieved, accurate analysis can be performed at extremely low content, and the detection signal is quickly read through the guidance of magnetic nano-gold particles, improving the detection efficiency and specificity of the sensor.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119082115A_ABST
    Figure CN119082115A_ABST
Patent Text Reader

Abstract

The invention relates to the technical field of biosensors, in particular to a magnetic nano electrochemical aptamer for detecting HSP70 and a sensor, and the nucleic acid sequence of the aptamer is SEQ No.1. The invention also relates to a magnetic nano electrochemical aptamer sensor for detecting the HSP70, and the aptamer sensor comprises gold-coated magnetic Fe3O4 nanoparticles and an aptamer on the surface of the nanoparticles, the nucleic acid sequence of the aptamer is SEQ No. 1. The sensor prepared from the HSP70 aptamer connected with the magnetic nanoparticles has extremely high sensitivity to the HSP70, and accurate detection result analysis can be completed only with extremely low HSP70 content.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of biosensors, in particular to a magnetic nano-electrochemical aptamer sensor for detecting HSP70, and belongs to bioengineering technology innovation. Background Art

[0002] Nucleic acid aptamers are small oligonucleotide sequences or short-chain polypeptides obtained through in vitro screening. Aptamers can bind to corresponding ligands with high affinity and strong specificity, and can be used for the diagnosis of tumor markers and targeted treatment of cancer cells. Aptamers can recognize and bind tumor-related biomarkers with high specificity, so that specific tumor markers can be found in the early stages of tumors, thereby achieving early diagnosis of tumors. In particular, they can identify tumor markers in the blood, which has the advantage of extremely high specificity. In addition, nucleic acid aptamers can also be combined with imaging agents for in vitro and in vivo molecular imaging studies, to observe the distribution and dynamic changes of specific biological molecules in the body, and to monitor the development of the disease or the effect of treatment. Finally, nucleic acid aptamers can also be combined with anti-tumor drugs to form drug conjugates, and nucleic acid aptamers can be used to specifically identify cancer cells to achieve targeted cancer treatment.

[0003] Hepatocellular carcinoma (HCC) is one of the most common types of liver cancer, which originates from the hepatocytes of the liver. HCC usually develops on the basis of cirrhosis (extensive fibrosis and hardening of liver tissue), which is the result of long-term damage and repair of the liver.

[0004] Electrochemical aptamers are usually selected through SELEX technology (systematic evolution of ligands by exponential enrichment), which screens nucleic acid ligands (Aptamers) with high affinity to the target substance from a random single-stranded nucleic acid sequence library. The aptamer screening process involves artificial chemical synthesis of a library containing random oligonucleotide sequences, the total length of which is generally 70 to 100 nucleotides, with a random sequence of 20 to 40 nucleotides in the middle. After multiple rounds of screening, oligonucleotide sequences with high affinity and specificity to specific targets are finally obtained, namely aptamers.

[0005] The aptamers designed and screened by the existing technology can only achieve specific high affinity with the target substance, but cannot screen the targeted substance, especially cannot carry out the directed transfer of the targeted substance, resulting in significant restrictions on the application of nucleic acid aptamers in electrochemical analysis research. Summary of the invention

[0006] In view of the problem that the nucleic acid aptamers in the prior art have high affinity for target substances but do not have the function of directional transfer screening, the present invention provides a magnetic nano-electrochemical aptamer and a sensor for detecting HSP70.

[0007] In order to achieve the above-mentioned object of the invention, the present invention provides the following technical solutions: The first aspect of the present invention provides a nucleic acid aptamer: A magnetic nano-electrochemical aptamer for detecting HSP70, wherein the nucleic acid sequence of the aptamer is SEQ No. 1.

[0008] The second aspect of the present invention provides a nucleic acid aptamer sensor: A magnetic nanoelectrochemical aptamer sensor for detecting HSP70, wherein the aptamer sensor comprises gold-coated magnetic Fe3O4 nanoparticles and an aptamer on the surface of the nanoparticles; The nucleic acid sequence of the aptamer is SEQ No. 1; The nucleic acid aptamer sequence SEQ No. 1 is: CCAACAACCCAACTTGATTCACCGAACACTCGCGTGG. The nucleic acid aptamer sequence is the sequence of HSP70 aptamer APT7.

[0009] Furthermore, the aptamer is fixed on the surface of the nanoparticles via thiol groups, wherein the nanoparticles are Fe3O4@Au nanoparticles, i.e., gold-coated magnetic Fe3O4 nanoparticles.

[0010] That is, Fe3O4@Au nanoparticles are formed by wrapping magnetic Fe3O4 nanoparticles with gold.

[0011] The magnetic nano-electrochemical aptamer of HSP70 of the present invention has a connecting part of magnetic nano-gold particles, which can realize the directional movement of the nucleic acid aptamer under the action of an external magnetic field. The detection and diagnosis of HSP70 can be realized through the interaction between the residues on the aptamer and heat shock protein 70 (HSP70). HSP70 is an emergency protein induced to be expressed by cells under stress conditions. HSP70 family members control all aspects of cellular protein homeostasis. The upregulation of HSP70s expression in tumor cells is closely related to the formation of drug resistance during tumor treatment. By connecting the aptamer of the present invention to Fe3O4@Au nanoparticles, HSP70 can be screened with high selectivity, thereby realizing the diagnostic analysis of tumors, as well as the potential of targeted inhibition of HSP70 function, which is of great significance for the treatment of drug-resistant malignant tumors.

[0012] Purified HSP70 (purchased from MyBioSource), purified single-stranded oligonucleotide original library, the library consists of 40 nucleotides (5′-ATCCAGAGTGACGCAGCA-N40-TGGACACGGTGGCTTAGT-3′), flanked by 18 nucleotide primer binding sites at the 5′ and 3′ ends, and forward primer (5′-ATCCAGAGTGACGCAGCA-3′) and 5′ phosphorylated reverse primer (5′-ACTAAGCCACCGTGTCCA-3′) synthesized by Sigma-Aldrich (India). Among them, magnetic nanogold particles are also called magnetic gold nanoparticles. Different from conventional gold nanoparticles Au-NPs, the magnetic gold nanoparticles of the present invention are formed by coating a gold layer on the surface of magnetic ferroferric oxide, so they can be guided by magnetism and assist active magnetic field control, which is beneficial to detection and analysis.

[0013] The third aspect of the present invention provides a method for preparing a nucleic acid aptamer sensor: Furthermore, the present invention also provides a method for preparing the magnetic nano-electrochemical aptamer sensor for detecting HSP70, comprising the following steps: S1. Screening HSP70 aptamers: Screening an aptamer with HSP70 affinity by SELEX technology, wherein the aptamer comprises the nucleic acid sequence SEQ No. 1.

[0014] S2, preparation of Fe3O4@Au nanoparticles: heating a 0.1 ~ 0.5 wt% chloroauric acid solution, preferably a 0.2wt% HAuCl4 solution, to boiling under stirring; adding Fe3O4 nanoparticles, continuing heating and stirring for 5 ~ 20 minutes, and adding a 0.2 ~ 2 wt% trisodium citrate solution, preferably a 1wt% trisodium citrate solution dropwise; the amount of the trisodium citrate solution is 5% ~ 10% of the volume of the original feed solution; after the addition of the trisodium citrate solution, the color of the solution changes from brown to brick red; When the color stops changing, remove the heat source; after the solution cools to room temperature, separate the precipitate with a magnet and centrifuge; The separated nanomaterials are vacuum dried and redispersed to obtain Fe3O4@Au nanoparticles for later use; S3, ligation: the 5' end of the HSP70 aptamer screened in S1 is modified with thiol (-SH); Then, Fe3O4@Au nanoparticles were added, and the 5'-end of the nucleic acid aptamer was modified with thiol group and fixed on the surface of the Fe3O4@Au nanoparticles to obtain aptamer-modified Fe3O4@Au nanoparticles, which were magnetic nanoelectrochemical aptamer sensors for detecting HSP70.

[0015] The method of the present invention uses magnetic nano-gold particles for connection to the electrochemical aptamer sensor, and uses thiol groups to achieve effective connection between the aptamer and the magnetic core. After the aptamer and HSP70 form a specific bond, the Fe3O4@Au nanoparticles can play a directional guiding role, and the Fe3O4@AuNPs modified by the aptamer can also be fixed on the surface of the working electrode by magnetic force, and the concentration is optimized by gradually increasing the volume of the nanomaterial and using MCH to block the unbound sites. With the glassy carbon electrode with magnetic force as the working electrode, fast and efficient detection and analysis can be achieved.

[0016] Furthermore, the method further comprises: fixing the aptamer-modified Fe3O4@Au nanoparticles on a test strip or a sensor.

[0017] Preferably, after immobilization is completed, the sensor surface is rinsed with distilled water to remove any unimmobilized molecules and then stored at 4°C until use.

[0018] Compared with the prior art, the solution of the present invention has the following advantages: The sensor made of HSP70 aptamers connected to magnetic nanoparticles has extremely high sensitivity to HSP70 and only requires extremely low HSP70 content to complete accurate detection result analysis.

[0019] After the HSP70 protein forms a specific reaction, the corresponding detection signal can be quickly read on the sensor under the guidance of the external magnetic field. BRIEF DESCRIPTION OF THE DRAWINGS

[0020] Figure 1 Figure 2 is a schematic diagram of the SELEX BLI screening process.

[0021] Figure 2 The results of affinity measurement analysis were analyzed using BLI technology.

[0022] Figure 3 It is a schematic diagram of the manufacturing procedure and testing process of the HSP70 sensor.

[0023] Figure 4 The results of characterization of ferroferric oxide nanoparticles. Among them, (A) is the UV-visible absorption spectra of Fe3O4NPs, Fe3O4@AuNPs and AuNPs. (B) is the Fourier transform infrared spectrum of Fe3O4@Au-Apt7. (C) is the particle size of Fe3O4NPs and Fe3O4@AuNPs. (D) is the zeta potential of Fe3O4NPs, Fe3O4@AuNPs and Fe3O4@Au-Apt7.

[0024] Figure 5 The SEM micrographs of nanoparticles, where (A) is a high-magnification image of Fe3O4 nanoparticles NPs, (B) a low-magnification image of Fe3O4@AuNPs and (C, D, E) the corresponding EDX elemental maps.

[0025] Figure 6 The results of the characterization analysis of the products. Among them, (A) the response of antibody concentration and reaction time to ΔI was analyzed by differential pulse voltammetry (DPV); (B) and (C) are GC, Fe3O4NPs, Fe3O4@AuNPs and Fe3O4@Au-Apt7 CV characterization spectra, (D) GC, Fe3O4NPs, Fe3O4@AuNPs and Fe3O4@Au-Apt7 EIS spectra.

[0026] Figure 7 This is the experimental result of the interaction between the Fe3O4@Au-Apt7 modified GC electrode and HSP70 antigens of different concentrations in the solution.

[0027] Figure 8 This is a graph showing the experimental results of selectivity, stability and reproducibility of Fe3O4@Au-Apt7 immunosensor.

[0028] Fig. 9 The CD signal (Circular Dichroism) is generated by the interaction between HSP70 and Apt-7. DETAILED DESCRIPTION

[0029] The present invention will be further described in detail below in conjunction with the accompanying drawings and embodiments, but the embodiments do not limit the present invention in any form.

[0030] Example 1 A kind of nucleic acid aptamer screening and preparation process for detection, the main process flow is as follows Figure 3 As shown, the specific steps are as follows: Step 1: Screening library and primer design: The design of the starting library has a significant impact on the screening results, and the design of the fixed region directly affects the PCR amplification efficiency of the library. The average length of the primer region is 18 to 21 nucleotides (NucleoTide, nt, also called nucleic acid bases). When designing, it is necessary to ensure that it does not form self-dimerization during the amplification process to avoid the generation of non-specific PCR products during amplification.

[0031] Shorter primer regions have less impact on subsequent screening and are conducive to screening out more diverse sequences. The design of a library with partially complementary fixed sequences at both ends is conducive to obtaining nucleic acid aptamers with stable secondary structures, but at the same time there is a problem of relatively low diversity of the screened sequences, which may not be conducive to screening highly specific nucleic acid aptamers. Usually, the length of the random region is mostly 30~60 nt, among which 40 nt random regions are most commonly used. The design of short random regions is conducive to subsequent truncation and application, but it is more dependent on the structure and function of the binding site of the primer region, while longer random regions have the opportunity to find aptamers with larger size and more complex structure in the screening, which is conducive to obtaining aptamers with high specificity.

[0032] The total length of the initial library of biolayer interference SELEX is 76 nt, and the sequence is 5′-ATCCAGAGTGACGCAGCA-N40-TGGACACGGTGGCTTAGT-3′ (N represents any base among A, T, C, G, and N40 represents 40 arbitrary bases). The library contains a random sequence of 40 nt in the middle and constant primer binding sequences of 18 nt on both sides. The random sequence can give the initial library rich diversity, and the primer sequence is convenient for increasing the library capacity through PCR reaction.

[0033] The sequence of the forward primer F1 was 5′- ATCCAGAGTGACGCAGCA-3′; The sequence of the reverse primer R1 is 5'-ACTAAGCCACCGTGTCCA-3'.

[0034] Preparation of original library: 1 μL of 100 μM ssDNA library (from Shanghai Bioengineering) was added to 99 μL of binding buffer (0.1-1M NaCl), mixed and incubated at 95°C for 10 minutes, and then immediately cooled on ice to prevent re-hybridization of single-stranded sequences. Then, the solution was transferred to 37°C for 2 hours to allow it to present its respective tertiary conformation.

[0035] Step 2: Biolayer interferometry-based SELEX NTA sensors were activated using freshly prepared 10 mM PBST (pH = 7.2-7.4, phosphate-tween buffer, containing 0.3% Tween 20). HSP70 (10 μg / mL) was prepared in 10 mM PBST buffer, and the loading parameters used in the study are detailed in Table 1 below. Binding buffer (>10 14The oligomers were exposed to the NTA sensor loaded with HSP70. The binders bound to the target were fished out from the random oligomer pool and sequentially dissociated into different microtiter wells, which contained dissociation buffers with increasing ionic strength according to the binding affinity (0.1-1M). After multiple rounds of elution, the aptamers that remained on the surface of the NTA sensor and firmly bound to HSP70 were obtained. The aptamers were separated after HSP70 was degraded by proteinase K and then PCR amplified as the aptamer library for the next screening.

[0036] Table 1 below details the loading parameters used in the study, and the schematic diagram of the operation flow is shown in Figure 1 As shown, these steps are performed in different wells of a microplate.

[0037] Table 1: Loading kinetic parameters

[0038] The above steps are carried out in different wells of the microplate, namely Baseline: Binding buffer (0.1-1M NaCl), Loading: HSP70 (10 µg / mL) in PBST buffer, Binding: ssDNA in binding buffer, Dissociation: ssDNA in elution buffer.

[0039] Figure 1 As shown, a schematic diagram of the test and analysis process using the BLI method is used. Through repeated binding and dissociation, the binding strength between HSP70 and the aptamer is utilized to screen out the nucleic acid aptamer segment with the best binding affinity.

[0040] Each step well was filled with 200 µL of the corresponding solution. The step-wise protocol was performed in different wells of the sample microplate, i.e., baseline: binding buffer; association: binding buffer; dissociation: binding buffer with increasing ion concentration (0.1-1M NaCl). The target (epitope peptide) was attached to the NTA BLI sensor (Ni-NTA biosensor) via His tag and Ni ion coupling and exposed to the initial oligo library (10 14 Oligonucleotides) are separated for interaction and subsequent association. Oligomers with sufficient affinity for the target are fished out and sequentially dissociated into wells containing buffers of increasing ionic concentrations (0.1-1 M NaCl) to elute from low affinity oligomers to the highest affinity aptamers. The population of binders (aptamers) is collected, purified, amplified, and analyzed for the presence of

[0041] BLI-SELEX-based aptamer selection was performed on a BLI instrument Octet® Red96 system (FortéBio) using a 96-well plate in kinetic mode. Before loading the target peptide onto the NTA sensor, the sensor was incubated for 600 s in the biosensor tray within the Octet instrument, set at 30 °C for optimal kinetics.

[0042] In order to further enrich the high-affinity aptamer population (the copy number of a given aptamer may be low), the above process was repeated 9 times. Finally, the second-generation sequencing was performed to obtain the primary structure of the nucleic acid aptamer with high affinity. In order to ensure that each round of screening library is ssDNA, 5' phosphorylated primers were used for PCR amplification, and the 5' phosphorylated antisense strand in the double-stranded DNA was degraded by the λ exonuclease method, and then the next level of nucleic acid electrophoresis was performed to separate the next level of library.

[0043] The response gradually increased during the loading of His-tagged HSP70 onto the NTA sensor, which resulted in an increase in the thickness of the biolayer on the sensor surface, indicating the immobilization of HSP70.

[0044] The HSP70-coated sensor was then exposed to the initial library, and the aptamers were gradually separated according to the binding strength of HSP70 to the aptamer. The naive library consisting of a random oligomer pool interacted and bound to the target molecule, which had different affinities for HSP70 due to different structures and sequences. Multiple oligomers interacted with the target (not entirely unique sequences), and these oligomers were sequentially dissociated from the target by immersion in a single well containing dissociation buffers of increasing strength.

[0045] Real-time monitoring of the progress of SELEX showing the association-dissociation cycle of an HSP70-coated NTA sensor. A sharp increase in the binding response during the association step indicates the acquisition of sequences from the exposed oligomer library after the oligonucleotide / peptide complexes were allowed to dissociate in increasing NaCl concentrations (0.1-1 M), and subsequent dips were recorded sequentially, depicting a decrease in the biolayer formed on the sensor, after which the sequences fell off the HSP70-coated sensor.

[0046] Furthermore, to enrich other possible aptamers from the initial library, the process was repeated several times as Figure 2As shown in B. With the continuous screening of enriched sequences, the affinity continued to increase. In order to ensure the specificity of the nucleic acid aptamer, negative selection was performed using HSP90 and BSA-fixed NTA sensors and empty NTA sensors without any protein added during the screening process. After the last round of screening, the ssDNA sequence was sequenced by next-generation sequencing. The obtained sequences were aligned using (https: / / www.ebi.ac.uk / jdispatcher / ) and divided into different families according to their homology. Then, combining the Gibbs free energy (ΔG) and family sequence similarity, a sequence was selected from different families to determine the dissociation constant (Kd).

[0047] Step 3: Aptamer-antigen interaction studies The pool of positive aptamers selected for HSP70 was analyzed using BLI to confirm their affinity for the peptide. For the HSP70 aptamer-epitope interaction studies obtained in the above steps, a single HSP70-loaded sensor was immersed in the selected pool solution and the association / dissociation kinetics were observed for 600 seconds. The pools with the best binding affinity for each target epitope were selected and further confirmed for their interaction with HSP70.

[0048] Affinity measurements Affinity measurements were analyzed using BLI technology, HSP70 was immobilized on the sensor and sequentially immersed in increasing dilutions of each selected aptamer (0.625, 1.25, 2.5, 5, 10 nM). BLI kinetic analysis was performed on different concentrations of individual aptamers in the range of 0.625, 1.25, 2.5, 5, 10 nM to determine the average Kd value.

[0049] In order to avoid specific aptamers binding to HSP70 and then binding to the NTA sensor through other nonspecific ways, the screened aptamers were immobilized on the SA sensor and immersed in the well containing HSP70 to determine the Kd value. Various bioinformatics tools were used to characterize the obtained sequences through structural modeling and docking studies. These fully characterized aptamers were used to detect HSP70 using an electrochemical platform.

[0050] The resulting datasets were normalized to the reference sensor and globally fitted with a 1:1 binding model using FortéBio data analysis software. The affinities of the selected aptamers were estimated on Octet Red96. Figure 2 As shown in D, the BLI test shows that HSP70 is immobilized on the sensor, has good affinity for the target protein molecules, is extremely selectivity, and has a good concentration linear relationship.

[0051] For a simple binding reaction: [A] + [T] ⇌ [AT] Where A is the aptamer, T is the target, and the interaction between the aptamer and the target is represented by the dissociation constant of affinity: Kd = [A][T] / [AT] = koff / kon, which is the ratio between two rate constants, the dissociation rate constant (koff) and the association rate constant (kon). Using the above relationship, the average Kd value is estimated based on the average sum of the Kd values ​​at different concentrations.

[0052] Step 4: Molecular docking study The selected aptamer sequences were clustered into eight families for affinity analysis.

[0053] The secondary structures of the aptamers were predicted by the UNAfold Web server ( http: / / www.unafold.org / mfold / applications / dna-folding-form.php ) and the ImGQfinder Web server ( http: / / imgqfinder.niifhm.ru ), and the original aptamer sequences were analyzed and truncated to obtain shorter sequences.

[0054] The tertiary structure of the G-quadruplex was predicted by the QGRS Mapper Web server (https: / / bioinformatics.ramapo.edu / QGRS / index.php). The simulation environment simulated the binding buffer ion conditions [Na + ] = 0.10 M, [Mg 2+ ] = 0.005 M and the temperature was 37 °C. The putative secondary structure with the lowest ΔG predicted by UNAfold was further used to predict the aptamer 3D structure using Xiao Lab.

[0055] To test whether they interact with HSP70, we designed a circular dichroism (CD) analysis experiment. The experiment found that HSP70 interacted with Apt-7 and produced a CD signal at 230nm. Fig. 9 As shown. The obtained Apt-7 was sequenced by an outsourced gene sequencing company (Sangong Company), and the sequence of Apt-7 was CCAACAACCCAACTTGATTCACCGAACACTCGCGTGG. In addition, the secondary structure of the aptamer was proposed, and then the tertiary structure was predicted using the Xiao Lab server (http: / / biophy.hust.edu.cn / new / 3dRNA / create). Other tertiary structures were predicted using the XiaoLab server (http: / / biophy.hust.edu.cn / new / 3dRNA / create).

[0056] Then, HDOCK was used to study the interaction between potential aptamers and their epitope peptides, and the docking results were scored according to known ligand-target interactions, structures, and electrostatics. The aptamers were applied to docking simulations through the HDOCK Web service (http: / / hdock.phys.hust.edu.cn). The HDOCK Web service simulated the molecular docking between the HSP70 protein and the 3D structure of the aptamer, which means that the aptamer binds to the HSP70 protein at different sites. Finally, the secondary structure, tertiary structure, molecular docking results, and affinity determination results were analyzed, and the nucleic acid aptamers for in vitro diagnosis were selected: APT-7 and APT-4. Computer software analysis found that Apt-7 formed two stem-loop structures; Apt-4 formed one stem-loop result, and no G-quadruplex structure was found through structural prediction.

[0057] Finally, the interacting residues between HSP70 and aptamers in the docking model were identified by the PLIP web server (https: / / plip-tool.biotec.tu-dresden.de / plip-web / plip / index).

[0058] The affinity of these aptamers was measured by BLI, and it was found that Apt-4 and Apt-7 aptamers had high affinity (1.549 nM and 1.71 nM), indicating that BLI-SELEX selection can provide aptamers with high affinity. In addition, we measured the specificity of these aptamers with BLI and different non-specific proteins (BSA and HSP90), and found that these aptamers only interacted with HSP70 and not with other proteins, indicating that these aptamers have high specificity. In addition, we also tested the affinity of aptamers such as Apt-7 and Apt-4 in a mixed system in serum, and the results showed that the nucleic acid aptamers screened in serum samples still have good affinity.

[0059] Step 5: Synthesis and characterization of Fe3O4@Au nanoparticles Fe3O4@Au nanoparticles (NPs) were prepared by heating HAuCl4 solution (0.2%, 50 mL) to boiling under stirring. Fe3O4 NPs (50 mg) were added and continued to heat and stir for 15 min. Trisodium citrate (1%, 4 mL) was added dropwise, and the color of the solution changed from brown to brick red. When the color stopped changing, the heat source was removed. After the solution cooled to room temperature, the precipitate was separated by magnet and centrifuged (6500 rpg, 30 min). The separated nanomaterials were vacuum dried and redispersed (1 mg / mL). The nanoparticles were characterized using various spectrophotometric, microscopic and electrochemical tools, and finally used for the modification of electrochemical sensors.

[0060] Fe3O4NPs, Fe3O4@AuNPs and AuNPs were characterized by UV-visible spectroscopy. Figure 4 As shown in Figure A, the absorption spectrum of Fe3O4@AuNPs shows a characteristic plasma resonance band centered at about 530 nm similar to that of AuNPs, but AuNPs are wine red, while Fe3O4@AuNPs are brick red. The UV spectrum of Fe3O4@AuNPs solution shows a characteristic plasma resonance band centered at 560nm, while the UV spectrum of Fe3O4NPs solution does not have a characteristic plasma resonance band. The new peak at 560 nm is due to Au wrapping on the surface of Fe3O4NPs to form core-shell Fe3O4@AuNPs. This indicates that Fe3O4@AuNPs have been successfully prepared.

[0061] The FTIR spectrum of Fe3O4@Au-Apt7 is shown in Figure 4 The detailed FTIR properties of Fe3O4@AuNPs and Fe3O4NPs are listed in the supplementary material. Comparing the infrared spectra of Fe3O4@Au-Apt7 with Fe3O4NPs and Fe3O4@AuNPs, a peak at 3437 cm -1 The peak intensity at 1608 cm -1 and 1365 cm -1 A new absorption peak appears at , indicating that the thiol-modified nucleic acid aptamer is bound to Fe3O4@AuNPs.

[0062] like Figure 4 As shown in Figure C, the particle size analyzer detected that the diameter of Fe3O4@AuNPs was larger than that of Fe3O4NPs. Figure 4As shown in D, the zeta potential shows that after wrapping Au, the potential changes from -8.7 mV to -18.2 mV. After the nucleic acid aptamer is fixed, the zeta potential is -24.3 mV, indicating that the nucleic acid aptamer is successfully fixed.

[0063] The morphologies of Fe3O4NPs, Fe3O4@AuNPs and Fe3O4@Au-Apt7 were studied using scanning electron microscopy (SEM). Figure 5 As shown, in Figure 5 A in the figure shows that Fe3O4NPs are uniformly deposited on the substrate and present a nanosphere structure with an average diameter of 230nm. Figure 5 Figure B shows that Fe3O4NPs are completely wrapped by Au to form a more compact structure, making it easier for electrons to transfer in the Fe3O4@AuNPs film. Figure 5 The corresponding EDX elemental spectra in (C, D, E) show that the Fe3O4@AuNPs were successfully prepared by energy spectrum scanning. In order to explore the immobilization of Apt-7 and Fe3O4@AuNPs, Fe3O4@Au-Apt7 was tested by SEM energy spectrum, and it was found that the surface of Fe3O4@AuNPs wrapped by Apt-7 became blurred under the electron microscope and the Au element could not be scanned.

[0064] Step 6: Binding of HSP70 aptamers to Fe3O4@Au nanoparticles The 5' end of the nucleic acid aptamer is modified with a thiol group (-SH). The prepared Fe3O4@AuNPs can react with thiol bonds to form strong chemical bonds because the surface is coated with Au. The 5' end of the screened nucleic acid aptamer modified with a thiol group (-SH) is used for fixation on the surface of Fe3O4@AuNPs.

[0065] The prepared Fe3O4@AuNPs were dissolved and dispersed, and the aptamers modified with thiol (-SH) at the 5' end were added, and the aptamers were immobilized on the surface of Fe3O4@AuNPs by using the thiol bond to react with Au on the surface of the nanoparticles. Since the surface was coated with Au, it could react with the thiol bond to form a strong chemical bond, so the aptamers modified with thiol (-SH) at the 5' end could be screened for immobilization on the surface of Fe3O4@AuNPs.

[0066] Electrochemical Characterization and Optimization of Fe3O4@Au-Apt7 Immunosensor Uniform incubation of optimal concentration of Apt-7 on Fe3O4@AuNPs and blocking of inactive sites with MCH are two key steps in optimizing the immunosensor. Therefore, the concentration of antibody and blocking agent as well as the antibody incubation time are crucial. Different concentrations of Apt-7 (1.25μM, 2.5μM, 5μM, 10μM) were prepared in phosphate buffer solution (PBST, phosphate buffer containing 0.3% Tween 20, pH=7.3) and incubated on the surface of Fe3O4@AuNPs. The incubation time study included incubation of different concentrations of nucleic acid aptamers at different reaction times (i.e., 20, 40, 60, and 80min).

[0067] The effects of aptamer concentration and reaction time were detected by electrochemical immunosensor DPV response. The equation ΔI = I0-I i Calculate the change in current, where I0 and I i The values ​​represent the peak currents before and after the interaction with Apt-7. The ΔI value increases with the extension of the incubation time and reaches a stable period at 40 min. Figure 6 As shown in Figure A, it shows that Apt-7 completely covers the surface of Fe3O4@AuNPs.

[0068] In order to ensure the binding of the aptamer to Fe3O4@AuNPs, the incubation time was set to 60 min to continue the subsequent experiments.

[0069] In addition, the optimal aptamer concentration for incubation on the electrochemical sensor surface was investigated. As the antibody concentration increased, the ΔI value gradually increased and reached saturation at 2.5 μM. Based on these results, 10 μM was selected as the optimal concentration of the modified antibody. To minimize nonspecific binding, 1 mM MCH was used to block unbound sites at 37 °C, and the incubation time was optimized to 30 min.

[0070] Fe3O4NPs, Fe3O4@AuNPs and Fe3O4@Au-Apt7 were fixed on the working electrode surface by magnetic force. CV, DPV and EIS tests showed that Fe3O4@AuNPs showed lower resistance and higher conductivity in electrochemical tests compared with Fe3O4NPs because the surface was coated with Au, which changed the conductivity. After modification with nucleic acid aptamers, the surface resistance of the working electrode increased, resulting in a decrease in current. The results are as follows: Figure 6 As shown in B, C, and D.

[0071] Electrochemical Characterization Techniques CV experiments were performed with a scan rate of 100 mV / s and a potential scan from -0.4 to +1.4 V. EIS studies were recorded in the frequency range of 100 kHz-0.01 Hz with an amplitude of 0.005 V. DPV measurements were performed with an amplitude of 50 mV, a pulse width of 50 ms, a scan width of 16.7 s, and a pulse period of 500 ms. All these electrochemical measurements were performed using 1 mM K[Fe(CN)6] 3− / 4− conduct.

[0072] Step 7: Characterization of HSP70 aptamers Mediated impedance method is used to characterize: The working electrode used a glassy carbon electrode with magnetic force, and the aptamer-modified Fe3O4@AuNPs were fixed on the working electrode surface by magnetic force. The concentration was optimized by gradually increasing the volume of the nanomaterials and MCH was used to block the unbound sites. The sensor surface was rinsed with distilled water to remove any unfixed molecules and stored at 4°C when not in use.

[0073] The sensor characterization CHI660 was carried out using cyclic voltammetry (CV), electrochemical impedance spectroscopy (EIS) and differential pulse voltammetry (DPV) techniques in sequence using an electrochemical workstation.

[0074] The sensing bioassay was performed using EIS, where different amounts of HSP70 (0.01-200 ng / mL) were incubated for 10 min, followed by washing and impedance value measurement. Impedance graphs were recorded and the current maximum was plotted against the toxin concentration to analyze the detection range and limit of detection (LOD).

[0075] The cross-reactivity of Apt nanosensor was verified using bovine serum albumin (BSA), IL-2, TNF-α, HSP90, glucose, and urea.

[0076] The results are as follows Figure 7 As shown in Figure 2, the interaction between the Fe3O4@Au-Apt7 modified GC electrode and HSP70 antigens at different concentrations in solution. Figure 7 As shown in Figure A, the resistance of the EIS without HSP70 in potassium ferricyanide solution is the lowest and increases with the increase of HSP70 antigen concentration. This increase is attributed to the fact that more antigen molecules bind to the immobilized nucleic acid aptamer at a higher concentration of HSP70 antigen. The resistance is plotted against the antigen concentration to obtain a standard curve, as shown in Figure 2. Figure 7 Shown in B. The linear range is between 0.01 and 200 ng / mL.

[0077] The linear relationship is given by the equation Rct = 1543.55 × log (CHSP70 ) + 6699.21 (where Rct = resistance, CHSP70 type = HSP70 concentration in ng / mL). This linear equation showed a high correlation coefficient of 0.995 (R 2 ).

[0078] The limit of detection (LOD) was calculated using the formula LOD = (κ*σ) / S, where S = sensitivity, corresponding to the slope of the current vs. antibody curve. The standard deviation of the blank measurement is denoted as σ, the confidence level parameter κ is set to 3, and the statistical confidence level is 99.6%. The calculated LOD is 0.525 pg / mL. For the limit of quantification (LOQ), HSP70 samples with concentrations of 0.005 ng / mL, 0.0075 ng / mL, and 0.01 ng / mL were tested. Although the 0.005 ng / mL and 0.0075 ng / mL HSP70 samples had obvious current responses, the results of repeated experiments showed obvious fluctuations, indicating that such low concentrations of HSP70 could not be accurately detected, and the 0.01 ng / mL HSP70 sample could be accurately detected. Therefore, the LOQ of this sensor is considered to be 0.01 ng / mL.

[0079] The method of the present invention has a relatively wide linear range and a lower detection limit. In addition, only a simple modification of the nucleic acid aptamer modified by the Fe3O4@AuNPs surface is required to perform instant detection in clinical practice, and the applicability of the sensor is wide. By increasing the amount of nucleic acid aptamer loading on the working electrode modified by Fe3O4@AuNPs, the sensitivity can be improved.

[0080] Selectivity, stability and reproducibility of Fe3O4@Au-Apt7 immunosensor To investigate the potential interference of other members of the HSP family (such as HSP90) as well as metabolites in serum (including IL-2, TNF-α, glucose and urea) and BSA on the HSP70 impedance spectroscopy (EIS) signal, the selectivity of the sensor was verified. Based on the reference concentration range of these metabolites in normal human serum, the interfering concentrations of 0.5 ng / mL IL-2, 0.5 ng / mL TNF-α, 10 mg / mL glucose, 2 mg / mL urea, 10 ng / mL BSA and 10 ng / mL HSP90 were selected. After incubating 10 μL of the above solutions on different immunosensor chips, a slight change in resistance was detected. However, when these metabolites were mixed with 1 ng / mL HSP70 for detection, a significant increase in resistance (ΔRct) was observed, as shown in the results. Figure 8 As shown, the sensor has excellent selectivity.

[0081] Finally, the Fe3O4@Au-Apt7 modified immunosensor was used to repeatedly measure 1 ng / mL HSP70 every two days over two weeks. The relative standard deviation (RSD) of the measured resistance change was 5.54%, indicating that the prepared sensor has excellent stability.

[0082] Sensor reproducibility evaluation To evaluate the reproducibility of the sensor, six sets of sensors were prepared using the same experimental conditions. 0.1 ng / mL of HSP70 standard was introduced into simulated serum-like biological samples for EIS detection, and the results are shown in Table 2. Evaluation of the recovery of HSP70 in serum samples showed that the recovery ranged from 97.88% to 103.89%. This indicates that the immunosensor has acceptable accuracy, reliability, and consistency in clinical quantification of HSP70.

[0083] Table 2: Determination of HSP70 in simulated serum samples:

[0084] Example 2 Real sample analysis The nucleic acid aptamer fixed on the surface of Fe3O4@AuNPs prepared in Example 1 was fixed on the surface of the working electrode by using a glassy carbon electrode with magnetic force. The sensor surface was rinsed with distilled water to remove any unfixed molecules to obtain a detection sensor.

[0085] In order to further evaluate the practicality of the newly developed immunosensor in clinical applications, 10 different human serum samples were analyzed using the developed immunoassay and enzyme-linked immunosorbent assay (ELISA) methods to detect HSP70. Specifically, real human serum samples provided by the hospital were used, and human venous blood samples were kindly provided by Sichuan Provincial People's Hospital (Chengdu, China). The above sensor was used for detection, and the test results are shown in Table 3, indicating that the performance of the aptamer sensor of the present invention is excellent.

[0086] Table 3: Comparison of two methods for determining serum HSP70 levels

[0087] Among them, the serum sample preparation was carried out according to the common hospital method. Venous blood was collected in an anticoagulant tube as a sample. Within 30 minutes after collection, it was centrifuged at 1000×g and 2-8℃ for 15 min, and the supernatant was taken as a serum sample for detection. During the detection process, the serum sample was dripped onto the aptamer sensor. When the HSP70 antigen was present, the aptamer could interact with the antigen to generate a resistance signal. The corresponding signal was read to indicate that the sample provider had a high level of HSP70 emergency response protein. Further clinical diagnosis was performed to review the test results. The results showed that 40% of the sample providers with positive aptamer sensors were liver cancer patients, and the diagnostic accuracy was 100%.

[0088] Comparison of the detection of HSP70 using the proposed immunosensor and the reference method (ELISA). Compared with the existing sensors, the immunosensor of the present invention shows advantages in linear detection range, detection limit, and recovery rate, as shown in Table 4, which further confirms the superiority of the sensor.

[0089] Table 4: Analytical performance of different detection methods for HSP70.

[0090]

Claims

1. A magnetic nano-electrochemical aptamer for detecting HSP70, characterized in that: The nucleic acid sequence of the aptamer is SEQ No.

1.

2. A magnetic nano-electrochemical aptamer sensor for detecting HSP70, characterized in that: The aptamer sensor comprises gold-coated magnetic Fe3O4 nanoparticles, and an aptamer on the surface of the nanoparticles; The nucleic acid sequence of the aptamer is SEQ No.

1.

3. A magnetic nano-electrochemical aptamer sensor for detecting HSP70 according to claim 1, characterized in that: The aptamer is fixed on the surface of the nanoparticle via thiol groups.

4. The magnetic nano-electrochemical aptamer sensor for detecting HSP70 according to claim 2, characterized in that: The nanoparticles are Fe3O4@Au nanoparticles; the Fe3O4@Au nanoparticles are formed by wrapping magnetic Fe3O4 nanoparticles with gold.

5. A method for preparing a magnetic nano-electrochemical aptamer sensor for detecting HSP70 according to claims 2-4, characterized in that: The following steps are involved: S1. Screening HSP70 aptamers: Screening an aptamer with HSP70 affinity by SELEX technology, wherein the aptamer comprises the sequence of the nucleic acid sequence SEQ No. 1; S2. Preparation of Fe3O4@Au nanoparticles: Heat a 0.1 to 0.5 wt% chloroauric acid solution to boiling under stirring; add Fe3O4 nanoparticles, continue heating and stirring for 5 to 20 minutes, and add 0.2 to 2 wt% trisodium citrate solution dropwise, wherein the amount of trisodium citrate solution is 5% to 10% of the volume of the original feed solution; after the reaction of adding the trisodium citrate solution, the color of the solution changes from brown to brick red; When the color stops changing, remove the heat source; after the solution cools to room temperature, separate the precipitate with a magnet and centrifuge; The separated nanomaterials are vacuum dried and redispersed to obtain Fe3O4@Au nanoparticles for later use; S3, ligation: the 5' end of the HSP70 aptamer screened in S1 is modified with a thiol group; Then, Fe3O4@Au nanoparticles were added, and the 5'-end of the nucleic acid aptamer was modified with thiol and fixed on the surface of the Fe3O4@Au nanoparticles to obtain aptamer-modified Fe3O4@Au nanoparticles.

6. The method for preparing the magnetic nano-electrochemical aptamer sensor for detecting HSP70 according to claim 4, characterized in that: Also includes: The aptamer-modified Fe3O4@Au nanoparticles are fixed on the test strip or sensor.

7. The method for preparing the magnetic nano-electrochemical aptamer sensor for detecting HSP70 according to claim 6, characterized in that: After immobilization was complete, the sensor surface was rinsed with distilled water to remove any unimmobilized molecules and then stored at 4 °C until use.